Panel Discussion: How Are Regulators & Industry Thinking About Degraders from a Safety Perspective in 2025?
Time: 10:00 am
day: Day One AM
Details:
Moderator: Zoran Rankovic, Director, Centre for Protein Degradation, The Institute for Cancer Research
- What if anything has changed on the FDA side with regards regulation of degraders?
- What is the pre-clinical and clinical data telling us thus far for degraders?
- Where are the opportunities for collaboration between stakeholders to drive these needs forward?
